BRICKELL BIOTECH INC (BBI)
US10802T2042 - Common Stock
| MRQ (2022-3-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 17.29M | 26.88M | 30.10M | 7.20M | 11.90M | |||
| Marketable Securities | N/A | N/A | 0.00 | 4.50M | 36.20M | |||
| Receivables | N/A | N/A | N/A | N/A | 0.00 | |||
| Other Current Assets | 3.40M | 2.72M | 3.40M | 6.20M | 1.10M | |||
| Total Current Assets | 20.69M | 29.60M | 33.50M | 18.00M | 49.20M | |||
| Non-Current Assets | ||||||||
| PPE Net | 96.00K | 117.00K | 100.00K | 200.00K | 100.00K | |||
| Investments And Advances | N/A | N/A | N/A | N/A | 2.40M | |||
| Intangibles | N/A | N/A | N/A | 0.00 | 0.00 | |||
| Other Non-Current Assets | N/A | N/A | N/A | N/A | 700.00K | |||
| Total Non-Current Assets | 96.00K | 117.00K | 100.00K | 100.00K | 3.10M | |||
| TOTAL ASSETS | 20.79M | 29.72M | 33.60M | 18.10M | 52.30M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 300.00K | 0.00 | 0.00 | |||
| Accrued Expenses | 1.76M | 3.21M | 5.50M | 6.50M | 3.10M | |||
| Accounts Payable | 2.98M | 1.60M | 600.00K | 2.20M | 400.00K | |||
| Other Current Liabilities | N/A | N/A | 0.00 | 1.80M | 0.00 | |||
| Total Current Liabilities | 4.74M | 4.81M | 6.40M | 10.50M | 3.60M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 100.00K | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | N/A | N/A | 0.00 | 100.00K | N/A | |||
| Total Non-Current Liabilities | 0.00 | 0.00 | 100.00K | 100.00K | 0.00 | |||
| TOTAL LIABILITIES | 4.74M | 4.81M | 6.50M | 10.60M | 3.60M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -154.78M | -145.37M | -105.90M | -85.00M | -442.10M | |||
| Additional Paid In Capital | 169.63M | 169.08M | 132.50M | 92.50M | 490.30M | |||
| Common Shares | 1.19M | 1.19M | 500.00K | 100.00K | 200.00K | |||
| Other Shareholders' Equity | N/A | N/A | 0.00 | 0.00 | 300.00K | |||
| Shares Outstanding | 2.65M | 2.65M | 53.60M | 8.50M | 3.10M | |||
| Tangible Book Value per Share | 6.05 | 9.39 | 0.51 | 0.89 | 15.74 | |||
| Total Shareholders' Equity | 16.05M | 24.91M | 27.10M | 7.60M | 48.80M | |||
| TOTAL LIABILITIES AND EQUITY | 20.79M | 29.72M | 33.60M | 18.10M | 52.30M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | 0.01 | N/A | N/A | |||
| Current Ratio | 4.36 | 6.15 | 5.23 | 1.71 | 13.67 | |||
| Return On Assets (ROA) | -191.83% | -132.83% | -62.23% | -131.93% | -31.07% | |||
| Return On Equity (ROE) | -248.50% | -158.49% | -77.16% | -314.21% | -33.30% | |||
All data in USD